Category: news 2018

Researchers can now share unpublished data securely on the blockchain Global AI company Innoplexus launched today a groundbreaking blockchain platform to dramatically increase the amount of data available for drug research and discovery. This new platform—an update to Innoplexus’ flagship product iPlexus —is the first of its kind, and will allow researchers to upload and …

Innoplexus launches Blockchain platform to drive Pharma innovation Read More »

In the last five years, data science has continued to make rapid advances, particularly in the fields of machine learning and deep learning. Organisations now have troves of raw data which, when combined with insights garnered from powerful and sophisticated analytics tools, can improve operational performance and create new market opportunities. However, while the tools …

Beyond competition, Innoplexus believes in collaboration to nurture the ecosystem in a data-driven world Read More »

Hosted by radio and TV personality Craig Sewing, ‘The American Dream’ is a national cable talk show that goes against the grain of all the negative stuff you keep seeing in the media. The American Dream is the only TV show that goes against the negative sensationalist style of journalism often seen in media. The …

Gunjan Bhardwaj on “The American Dream” Read More »

Artificial intelligence (AI) has recently garnered a lot of attention, and it is transforming the way pharma execs use their data. tech emergency, an AI market research company, recently revealed that interest in pharma-related AI articles has gone up by more than 10 times in the last year. What’s more, over 50% of healthcare industry …

When should pharma execs actually care about AI? Read More »

Despite the millions of lives that are saved by pharmaceutical drugs each year, the pharmaceutical industry struggles against an enduring bad reputation. It’s not difficult to find statistics attesting to the frustration that many consumers feel about rising drug prices, corruption, and other real challenges that pharmaceutical companies face. But despite the negative public opinion, …

Consumer perceptions of pharma Read More »

Pharmaceutical companies spend a tremendous amount of money each year on advertising and marketing. According to the Pew Charitable Trusts, “In 2012, the pharmaceutical industry spent more than $27 billion on drug promotion — more than $24 billion on marketing to physicians and over $3 billion on advertising to consumers.“ This strategy is designed to …

How Blockchain And AI Can Help Pharma Focus On Innovation Rather Than Advertising Read More »

The risky and unpredictable nature of the clinical trial process is a major driver of high costs for pharmaceutical
drugs. To justify the costs of drug development, most pharmaceutical companies aim to develop 2-3 new drugs per
year, but the success rate and long development timelines with clinical trials diminish the chances of a successful
product to nearly zero.

Pharma should lean more on the power of big data and AI to identify and target individuals who possess the greatest social capital and influence relevant to a given therapeutic area. The phrase “opinion leader” became popular after Paul Lazarsfeld and Elihu Katz wrote about it in their 1955 book Personal Influence: The Part Played …

Big data, AI and social media are the changing face of pharma marketing Read More »

It’s widely known by the pharmaceutical community that nearly nine out of ten drug candidates fail to win FDA approval, resulting in enormous drug development expenses every year. Less commonly understood is the underlying cause of these high failure rates, and what the pharmaceutical industry can do to overcome this challenge. Currently, in an effort …

How AI And Blockchain Can Revolutionize Pharmaceutical Trials Read More »